List view / Grid view
The approval provides paediatric epilepsy patients a treatment option which…
The approval provides paediatric epilepsy patients a treatment option which can be initiated at a therapeutic dose from day one...
FDA approves Vimpat for partial-onset seizures in paediatric epilepsy patients…
FDA approves Vimpat for partial-onset seizures in paediatric epilepsy patients as an oral solution or a convenient tablet...
UCB has announced that the EC has approved the use…
UCB has announced that the EC has approved the use of its anti-epileptic drug Vimpatas in the treatment of partial-onset seizures...
